Biocryst Pharmaceuticals buy StockNews.com
Start price
28.06.25
/
50%
€7.92
Target price
28.06.26
-
Performance (%)
6.99%
Price
10.04.26
€8.16
Summary
This prediction is currently active. The BUY prediction by StockNews_com shows slight gains of 6.99%. This prediction currently runs until 28.06.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | 4.242% | 4.242% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by StockNews_com for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for BCRX provided by MarketBeat